0001708135-26-000003.txt : 20260921 0001708135-26-000003.hdr.sgml : 20260921 20260921161636 ACCESSION NUMBER: 0001708135-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260921 DATE AS OF CHANGE: 20260921 EFFECTIVENESS DATE: 20260921 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avery Therapeutics, Inc. CENTRAL INDEX KEY: 0001708135 ORGANIZATION NAME: EIN: 464845790 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598273 FILM NUMBER: 261394129 BUSINESS ADDRESS: STREET 1: 2500 N. TUCSON BLVD. STE. 140 CITY: TUCSON STATE: AZ ZIP: 85716 BUSINESS PHONE: 520-977-4980 MAIL ADDRESS: STREET 1: 2500 N. TUCSON BLVD. STE. 140 CITY: TUCSON STATE: AZ ZIP: 85716 D 1 primary_doc.xml X0708 D LIVE 0001708135 Avery Therapeutics, Inc. 2500 N. TUCSON BLVD. STE. 140 TUCSON AZ ARIZONA 85716 520-977-4980 DELAWARE None None Corporation true Jordan Lancaster c/o Avery Therapeutics, Inc. 2500 N. Tucson Blvd., Suite 140 Tucson AZ ARIZONA 85716 Executive Officer Director Lawrence Mehren c/o Avery Therapeutics, Inc. 2500 N. Tucson Blvd., Suite 140 Tucson AZ ARIZONA 85716 Director Emile Nuwaysir c/o Avery Therapeutics, Inc. 2500 N. Tucson Blvd., Suite 140 Tucson AZ ARIZONA 85716 Director Steven Goldman c/o Avery Therapeutics, Inc. 2500 N. Tucson Blvd., Suite 140 Tucson AZ ARIZONA 85716 Executive Officer Biotechnology Decline to Disclose 06b false 2026-08-19 false true false 0 15400000 8468859 6931141 false 23 0 0 0 false Avery Therapeutics, Inc. /s/ Jordan Lancaster Jordan Lancaster Chief Executive Officer 2026-09-21